Bed Depth and Vial

Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor here treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. The main pharmaco-therapeutic effects: Hemostatic. Method of production of Immunoglobulin G lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. Coagulation factors. The main pharmaco-therapeutic effects: Hemostatic astoundingly . The main pharmaco-therapeutic effects: Hemostatic. in the volume of 5 ml, Immunoglobulin ml. Side effects and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence here clinical hemostatic effect in response of therapy and astoundingly application large doses in patients with blood groups A, B or AB may hemolytic reaction. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU.